Lyme Science Blog

In 1998, the first Lyme disease vaccine was introduced by LYMErix but it was pulled from the market after 3 years due to poor sales and possible safety concerns. The FDA was never able to confirm that the vaccine caused harm despite concerns. Only recently have drug makers resumed researching new human Lyme vaccines. “But […]

The authors cited the World Health Organizations definition of Long COVID as follows: definition of Post COVID-19 – “Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at least 2 months and cannot be explained

The authors looked at patients admitted to their infectious disease clinic in Australia between 2014 – 2020. “Patients were included if they had debilitating symptoms suggested by either themselves or the referring clinician as being attributed to ticks.” They acknowledged that there are ill patients who have been seen at their infectious disease clinic who

In their study, “Human attachment site preferences of ticks parasitizing in New York,” Hart and colleagues describe which body parts black-legged and lone star ticks prefer to bite.¹ They collected ticks, submitted between April and December 2020 from individuals living in New York State, along with online questionnaires indicating where the tick was attached. They

In their article entitled “Common Neurologic Features of Lyme Disease That May Present to a Rheumatologist,” Govil et al. describe the various ways that Lyme disease can affect the brain. The authors hope to make rheumatologists aware of the most common neurologic presentations of Lyme disease.1 It is particularly important, the authors write, for rheumatologists

In their article “Lyme neuroborreliosis with encephalitis: A rare case,” Rosendahl and colleagues describe a 74-year-old immunocompromised woman, who was admitted to the hospital with confusion, paranoid delusions, weight loss, back pains, and a history of fever and vomiting suspect of cancer and infection of unknown origin.¹ The woman had been hospitalized 4 times over

In their article “Supportive Oligonucleotide Therapy (SOT) as a Potential Treatment for Viral Infections and Lyme Disease: Preliminary Results,” Apostolou and colleagues describe findings from a study aimed to evaluate the efficacy of SOT in 115 patients with either Epstein–Barr (EBV), Herpes Simplex Virus or Lyme Disease.¹ Oligonucleotide was administered intravenously to the participants and

In their study, “Impacts Over Time of Neighborhood-Scale Interventions to Control Ticks and Tick-Borne Disease Incidence,” Ostfeld and colleagues examined the effectiveness of tick control methods in 24 residential neighborhoods endemic for Lyme disease in New York.¹ The study, conducted over several years, assessed the impact of tick control system (TCS) bait boxes and Met52